4//SEC Filing
Pourhassan Nader 4
Accession 0001807094-20-000017
CIK 0001175680other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 6:08 PM ET
Size
7.5 KB
Accession
0001807094-20-000017
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Pourhassan Nader
Chief Operating Officer
Transactions
- Award
Common Stock
2020-09-30+500,000→ 1,574,930 total - Award
Non-qualified Stock Option
2020-09-30+2,000,000→ 2,000,000 totalExercise: $3.12Exp: 2030-06-15→ Common Stock (2,000,000 underlying)
Footnotes (4)
- [F1]Represents restricted stock units granted pursuant to the Issuer's Amended & Restated 2012 Equity Incentive Plan.
- [F2]Not applicable.
- [F3]The option grant was approved by a committee of the Issuer's Board of Directors on June 15, 2020, subject to stockholder approval of the Issuer's Amended & Restated 2012 Equity Incentive Plan (the "Plan") under which the option was granted. The Issuer's stockholders approved the Plan on September 30, 2020.
- [F4]The stock option vests annually in three equal installments beginning June 15, 2021.
Documents
Issuer
CytoDyn Inc.
CIK 0001175680
Entity typeother
Related Parties
1- filerCIK 0001532878
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 6:08 PM ET
- Size
- 7.5 KB